Cero Therapeutics Holdings Stock Price History
CEROW Stock | 0.02 0.0007 4.86% |
If you're considering investing in CERo Stock, it is important to understand the factors that can impact its price. As of today, the current price of CERo Therapeutics stands at 0.02, as last reported on the 31st of January, with the highest price reaching 0.02 and the lowest price hitting 0.01 during the day. CERo Therapeutics is out of control given 3 months investment horizon. CERo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 5.11% are justified by taking the suggested risk. Use CERo Therapeutics mean deviation of 20.89, and Risk Adjusted Performance of 0.1544 to evaluate company specific risk that cannot be diversified away.
Common Stock Shares Outstanding is likely to climb to about 9.7 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (12.1 M). . Price Earnings Ratio is likely to climb to about (309.3 M) in 2025. Price Book Value Ratio is likely to climb to about (55.3 K) in 2025. CERo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CERo |
Sharpe Ratio = 0.1645
Best Portfolio | Best Equity | CEROW | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
31.09 actual daily | 96 96% of assets are less volatile |
Expected Return
5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average CERo Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CERo Therapeutics by adding it to a well-diversified portfolio.
Book Value (2.27) | Shares Float 22.5 M | Shares Short Prior Month 20.3 K | Shares Short 25.5 K |
CERo Therapeutics Stock Price History Chart
There are several ways to analyze CERo Stock price data. The simplest method is using a basic CERo candlestick price chart, which shows CERo Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 20, 2024 | 0.0239 |
Lowest Price | November 7, 2024 | 0.0051 |
CERo Therapeutics January 31, 2025 Stock Price Synopsis
Various analyses of CERo Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CERo Stock. It can be used to describe the percentage change in the price of CERo Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CERo Stock.CERo Therapeutics Price Rate Of Daily Change | 1.05 | |
CERo Therapeutics Price Daily Balance Of Power | 0.15 |
CERo Therapeutics January 31, 2025 Stock Price Analysis
CERo Stock Price History Data
The price series of CERo Therapeutics for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 0.02 with a coefficient of variation of 39.54. The prices are distributed with arithmetic mean of 0.01. The median price for the last 90 days is 0.01.Open | High | Low | Close | Volume | ||
01/31/2025 | 0.01 | 0.02 | 0.01 | 0.02 | ||
01/30/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 371,585 | |
01/29/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 40,518 | |
01/28/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 206,144 | |
01/27/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 89,140 | |
01/24/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 77,753 | |
01/23/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 51,572 | |
01/22/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 2,813 | |
01/21/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 82,086 | |
01/17/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 37,939 | |
01/16/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 56,685 | |
01/15/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 18,700 | |
01/14/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 10,311 | |
01/13/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 88,764 | |
01/10/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 24,834 | |
01/08/2025 | 0.03 | 0.03 | 0.01 | 0.02 | 120,912 | |
01/07/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 1,778,611 | |
01/06/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 675,517 | |
01/03/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 347,739 | |
01/02/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 27,740 | |
12/31/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 503,410 | |
12/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 84,157 | |
12/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 168,670 | |
12/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 59,580 | |
12/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 8,100 | |
12/23/2024 | 0.01 | 0.01 | 0 | 0.01 | 385,582 | |
12/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 28,819 | |
12/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 482,626 | |
12/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 42,593 | |
12/17/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 17,716 | |
12/16/2024 | 0.01 | 0.02 | 0.01 | 0.01 | 5,473 | |
12/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 15,180 | |
12/12/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 1,016 | |
12/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 18,801 | |
12/10/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 155,755 | |
12/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 186,277 | |
12/06/2024 | 0.02 | 0.02 | 0.01 | 0.01 | 248,394 | |
12/05/2024 | 0.01 | 0.02 | 0.01 | 0.02 | 44,854 | |
12/04/2024 | 0.02 | 0.02 | 0.01 | 0.01 | 23,499 | |
12/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 370.00 | |
12/02/2024 | 0.01 | 0.02 | 0.01 | 0.01 | 228,416 | |
11/29/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 22,666 | |
11/27/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 229,191 | |
11/26/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 11,000 | |
11/25/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 17,804 | |
11/22/2024 | 0.03 | 0.03 | 0.02 | 0.02 | 99,878 | |
11/21/2024 | 0.02 | 0.03 | 0.02 | 0.02 | 302,245 | |
11/20/2024 | 0.03 | 0.03 | 0.02 | 0.02 | 60,475 | |
11/19/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 135,885 | |
11/18/2024 | 0.02 | 0.02 | 0.01 | 0.02 | 223,581 | |
11/15/2024 | 0.01 | 0.02 | 0.01 | 0.02 | 1,490,489 | |
11/14/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 23,294 | |
11/13/2024 | 0.01 | 0.02 | 0 | 0.01 | 1,089,319 | |
11/12/2024 | 0.01 | 0.02 | 0.01 | 0.02 | 266,668 | |
11/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 287,808 | |
11/08/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 5,674 | |
11/07/2024 | 0.01 | 0.01 | 0 | 0.01 | 133,722 | |
11/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,151 | |
11/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,337 | |
10/31/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 262.00 |
About CERo Therapeutics Stock history
CERo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CERo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CERo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CERo Therapeutics stock prices may prove useful in developing a viable investing in CERo Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 5.9 M | 9.7 M |
CERo Therapeutics Stock Technical Analysis
CERo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
All Next | Launch Module |
CERo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CERo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CERo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CERo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1544 | |||
Jensen Alpha | 5.62 | |||
Total Risk Alpha | 2.0 | |||
Sortino Ratio | 0.2385 | |||
Treynor Ratio | (1.58) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.